C113H129ClN30O11 — CID 161038952
1-[4-[8-[(5-chloro-6-methyl-1H-indazol-4-yl)oxy]-2-[2-(dimethylamino)ethoxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[2-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-8-[(5-methyl-1H-indazol-4-yl)oxy]quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-methyl-1H-indazol-4-yl)oxy]-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-methyl-1H-indazol-4-yl)oxy]-2-[[(2R)-1-methylpyrrolidin-2-yl]methoxy]quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one (PubChem CID 161038952) has the molecular formula C113H129ClN30O11 and a molecular weight of 2118.93 g/mol. Its IUPAC name is 1-[4-[8-[(5-chloro-6-methyl-1H-indazol-4-yl)oxy]-2-[2-(dimethylamino)ethoxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[2-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-8-[(5-methyl-1H-indazol-4-yl)oxy]quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-methyl-1H-indazol-4-yl)oxy]-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-methyl-1H-indazol-4-yl)oxy]-2-[[(2R)-1-methylpyrrolidin-2-yl]methoxy]quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one.
| Compound Name | 1-[4-[8-[(5-chloro-6-methyl-1H-indazol-4-yl)oxy]-2-[2-(dimethylamino)ethoxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[2-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-8-[(5-methyl-1H-indazol-4-yl)oxy]quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-methyl-1H-indazol-4-yl)oxy]-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-methyl-1H-indazol-4-yl)oxy]-2-[[(2R)-1-methylpyrrolidin-2-yl]methoxy]quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one |
|---|---|
| PubChem CID | 161038952 |
| Molecular Formula | C113H129ClN30O11 |
| Molecular Weight | 2118.93 g/mol |
| Exact Mass | 2117.01 |
| IUPAC Name | 1-[4-[8-[(5-chloro-6-methyl-1H-indazol-4-yl)oxy]-2-[2-(dimethylamino)ethoxy]pyrido[3,4-d]pyrimidin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[2-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-8-[(5-methyl-1H-indazol-4-yl)oxy]quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-methyl-1H-indazol-4-yl)oxy]-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one;1-[4-[8-[(5-methyl-1H-indazol-4-yl)oxy]-2-[[(2R)-1-methylpyrrolidin-2-yl]methoxy]quinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one |
| SMILES | C=CC(=O)N1CCN(c2nc(N3CC[C@H](N(C)C)C3)nc3c(Oc4c(C)ccc5[nH]ncc45)cccc23)CC1.C=CC(=O)N1CCN(c2nc(OCCN(C)C)nc3c(Oc4c(Cl)c(C)cc5[nH]ncc45)nccc23)CC1.C=CC(=O)N1CCN(c2nc(OC[C@@H]3CCCN3C)nc3c(Oc4c(C)ccc5[nH]ncc45)cccc23)CC1.C=CC(=O)N1CCN(c2nc(OC[C@H]3CCCN3C)nc3c(Oc4c(C)ccc5[nH]ncc45)cccc23)CC1 |
| InChI | InChI=1S/C29H34N8O2.2C29H33N7O3.C26H29ClN8O3/c1-5-25(38)35-13-15-36(16-14-35)28-21-7-6-8-24(39-27-19(2)9-10-23-22(27)17-30-33-23)26(21)31-29(32-28)37-12-11-20(18-37)34(3)4;2*1-4-25(37)35-13-15-36(16-14-35)28-21-8-5-9-24(39-27-19(2)10-11-23-22(27)17-30-33-23)26(21)31-29(32-28)38-18-20-7-6-12-34(20)3;1-5-20(36)34-8-10-35(11-9-34)24-17-6-7-28-25(22(17)30-26(31-24)37-13-12-33(3)4)38-23-18-15-29-32-19(18)14-16(2)21(23)27/h5-10,17,20H,1,11-16,18H2,2-4H3,(H,30,33);2*4-5,8-11,17,20H,1,6-7,12-16,18H2,2-3H3,(H,30,33);5-7,14-15H,1,8-13H2,2-4H3,(H,29,32)/t3*20-;/m010./s1 |
| InChIKey | UAPXZPKVKPEPLX-GXVDCLFWSA-N |
| XLogP | 14.84 |
| TPSA | 405.74 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 33 |
| Rotatable Bonds | 28 |
| Heavy Atoms | 155 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2118.93 |
| LogP ≤ 5 | 14.84 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 33 |
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|